Corcept Therapeutics Stock Predictions

Crowdfunding to IPO: Nasdaq's Next Breakout?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

CORT
Corcept Therapeutics

Last Price:

$75.00

Seasonality Move:

6.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Corcept Therapeutics Stock Forecast

Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 42.5% based on the past 20 years of stock performance.
Corcept Therapeutics has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Is Corcept Therapeutics Stock Undervalued?

The current Corcept Therapeutics [CORT] share price is $74.65. The Score for CORT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
CORT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Corcept Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 42.5% based on the past 20 years of stock performance.

Corcept Therapeutics Stock Rating

Buy

Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics overpriced?

Corcept Therapeutics has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Corcept Therapeutics Stock Price History

Is CORT stock going to rise?

The current trend is moderately bullish and CORT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

corcept.com

52-Week Data

52-Week High:

117.33

52-Week Low:

20.84

Prediction Charts

Market Cap:

Price in USD:

74.65

Volume:

2.6M

Beta:

0.76

Technical Analysis

SMA50:

64.92

SMA100:

60.08

SMA200:

49.10

52-Wk Change:

196.23%

Stock Predictions

Is Corcept Therapeutics stock public?

Yes, Corcept Therapeutics is a publicly traded company.
What is the Corcept Therapeutics stock quote today?

The Corcept Therapeutics stock price is 74.65 USD today.
How to buy Corcept Therapeutics stock online?

You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-19	56.07	58.00	58.61	55.64
Mar-20	57.32	57.59	59.72	57.02
Mar-21	56.74	58.66	59.14	56.33
Mar-24	59.96	59.47	61.09	59.37
Mar-25	59.50	58.32	60.04	57.86
Mar-26	58.26	57.11	58.76	56.52
Mar-27	56.81	56.68	57.71	56.64
Mar-28	56.82	54.63	57.51	53.79
Mar-31	94.93	114.22	117.33	87.58
Apr-1	114.68	91.93	114.71	91.06
Apr-2	89.44	83.81	90.50	82.84
Apr-3	79.16	79.37	82.96	77.01
Apr-4	77.60	74.45	78.00	72.59
Apr-7	72.89	74.65	77.49	69.04

Corcept Therapeutics Earnings

Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Corcept Therapeutics Forecast Revenue Growth

Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.

* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.